ConductScience.org, home

Paper29550930

Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa.

Uchiyama J and 10 others. Arch Virol, 2018. Cited by 69 papers, by iCite.

Cite this record

ConductScience Library. Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa. Papers, record 29550930. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29550930

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa.
PubMed
Journal
Arch Virol
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
3.52
iCite
Revised in PubMed
2018-07-09
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Uchiyama JJumpei
2Shigehisa RRyu
3Nasukawa TTadahiro
4Mizukami KKeijiro
5Takemura-Uchiyama IIyo
6Ujihara TTakako
7Murakami HHironobu
8Imanishi IIchiro
9Nishifuji KKoji
10Sakaguchi MMasahiro
11Matsuzaki SShigenobu

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
CeftazidimeMajor topic
MyoviridaeMajor topic
PiperacillinMajor topic
Pseudomonas PhagesMajor topic
Pseudomonas aeruginosaMajor topic
Humans
Microbial Sensitivity Tests
Phage Therapy

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Grant-in-Aid for Young Scientists (15K19095)Japan Society for the Promotion of SciencePubMed

Source PubMed

Download CSV of grants

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
41750535Natural Products as Potentiators of β-Lactam Antibiotics: A Review of Mechanisms, Advances, and Future Directions.Antioxidants (Basel)2026https://conductscience.org/library/papers/41750535PubMed
41471203Characterisation of a Novel Pseudomonas Phage and Its Effect on the Survival of Galleria mellonella Larvae.Pathogens2025https://conductscience.org/library/papers/41471203PubMed
41039237Characterization of bacteriophages PAA and PAM and evaluation of their antibiotic synergy against Pseudomonas aeruginosa PAZMYU isolated from urine sample.BMC Microbiol2025https://conductscience.org/library/papers/41039237PubMed
40644532Wearing bacteriophages individually with an adhesive drug-loadable nanohelmet for treating ocular infections.Sci Adv2025https://conductscience.org/library/papers/40644532PubMed
40636524Combined Forces Against Bacteria: Phages and Antibiotics.Health Sci Rep2025https://conductscience.org/library/papers/40636524PubMed
40635382Phage-Antibiotic Combinations for Pseudomonas: Successes in the Clinic and In Vitro Tenuously Connected.Microb Biotechnol2025https://conductscience.org/library/papers/40635382PubMed
40575641Synergistic efficacy of phages along with vancomycin for eradication of vancomycin-resistant Enterococcus faecalis biofilms.World J Virol2025https://conductscience.org/library/papers/40575641PubMed
40508147Phage-Antibiotic Synergy Enhances Biofilm Eradication and Survival in a Zebrafish Model of Pseudomonas aeruginosa Infection.Int J Mol Sci2025https://conductscience.org/library/papers/40508147PubMed
40383795Phage-antibiotic synergy to combat multidrug resistant strains of Gram-negative ESKAPE pathogens.Sci Rep2025https://conductscience.org/library/papers/40383795PubMed
40185918Bacteriophage Indie resensitizes multidrug-resistant Acinetobacter baumannii to antibiotics in vitro.Sci Rep2025https://conductscience.org/library/papers/40185918PubMed
40143863Phage-antibiotic combinations against Klebsiella pneumoniae: impact of methodological approaches on effect evaluation.Front Microbiol2025https://conductscience.org/library/papers/40143863PubMed
40114780Formulation of Bacteriophage for Inhalation to Treat Multidrug-Resistant Pulmonary Infections.Kona2025https://conductscience.org/library/papers/40114780PubMed
40013014Oral bacteriophages and their potential as adjunctive treatments for periodontitis: a narrative review.J Oral Microbiol2025https://conductscience.org/library/papers/40013014PubMed
39704503Temperate phage-antibiotic synergy is widespread-extending to Pseudomonas-but varies by phage, host strain, and antibiotic pairing.mBio2025https://conductscience.org/library/papers/39704503PubMed
39334975Bacteriophage Therapy on an In Vitro Wound Model and Synergistic Effects in Combination with Beta-Lactam Antibiotics.Antibiotics (Basel)2024https://conductscience.org/library/papers/39334975PubMed
39066214Pseudomonas aeruginosa Bacteriophages and Their Clinical Applications.Viruses2024https://conductscience.org/library/papers/39066214PubMed
38772946Phage Therapy for Respiratory Infections: Opportunities and Challenges.Lung2024https://conductscience.org/library/papers/38772946PubMed
38757974Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny.mBio2024https://conductscience.org/library/papers/38757974PubMed
38653744Phage-antibiotic combinations to control Pseudomonas aeruginosa-Candida two-species biofilms.Sci Rep2024https://conductscience.org/library/papers/38653744PubMed
38084971Exploiting phage-antibiotic synergies to disrupt Pseudomonas aeruginosa PAO1 biofilms in the context of orthopedic infections.Microbiol Spectr2024https://conductscience.org/library/papers/38084971PubMed

See all 53 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29550930

GET https://conductscience.org/api/papers/v1/29550930/cited_by?page=2